The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  Johnson & Johnson (JNJ)     Sector: Healthcare  >  Industry: Major Drugs
ETFI Global Healthcare Sector PerformIdex

Nov 08, 2008 11:54 PM GMT
Mikerun
Return Risk
+1.04% MID
Principal

ETFI Global Healthcare Sector PerformIdex



The accompanying table presents the top six rated companies with market caps of at least $250 million (USD) from each of the eight ETFI healthcare indexes (which include a database of about 320 companies) as equally-weighted components in the ETFI Global Healthcare Sector PerformIdex of 48 companies.

1.) ETFI Global Hospitals
2.) ETFI New Drug Regulatory Catalyst
3.) ETFI Global AnimalBiz
4.) ETFI Health Benefit Providers
5.) ETFI Cosmetic & Reconstructive Medicine
6.) ETFI Global Generic Drugs
7.) ETFI Global Health Information Technology
8.) ETFI Preventive Medicine

This index and new ETF idea is designed to provide investors with more diversified exposure in terms of geography, market cap range, and healthcare business segment as compared to the existing sector-based health ETFs which are analyzed in this article and tend to own similar large-cap healthcare stocks such as Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Labs (ABT) on an overweight basis.

While this index also has some exposure to widely held names such as JNJ, ABT, and Genentech (DNA); it is structured as an equally weighted index with quarterly updates and includes more diverse exposure to a wider range of small and mid-cap companies such as Osiris Therapeutics (OSIR), Sequenom (SQNM), SXC Health Solutions (SXCI), Neogen (NEOG), and other companies on a global basis.


JNJ:  This call was made on 11/08/08 @ $61.0
Rating:   Positive   $61.0 (11/08/08)
Closed:   11/21/2008 @ $55.2135 (-9.49% in 13 days)


Comments (1)

Add Comment

Arrow_up
Arrow_down
ozipek   N/A     1 point   commented 411 days ago reply

biber hapı | Maurers | zayıflama | Lw6090 | altın çilek | Ozon Yağı | Red Pepper | fx15 | radian | Tengda | Tengda Zayıflama Hapı | Tengda Kullanımı | Tengda Kullanıcı Yorumları | Tengda Sipariş | Tengda Hakkında | Tengda İçindekiler | Tengda Etkileri | Tengda Yan Etkileri | Maurers | Maurers Kullanımı | Maurers Kullanıcı Yorumları | Maurers Sipariş | Maurers Hakkında | Maurers Zayıflama Hapı | Maurers İçindekiler | Maurers Etkileri | Maurers Yan Etkileri |


Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Johnson & Johnson (JNJ)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
84.0%
Top:
64.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
AMRN Positive +86.01% 11/29/10
IBB Positive +39.69% 11/22/10
EXAS Positive +35.19% 10/21/10
BIOD Positive -83.37% 10/17/10
LCI N/A Positive -21.73% 10/06/10

View All >
   
Mike Havrilla previously rated JNJ
Positive +1.93% Epinex Diagnostics: A New Paradigm for Diabetic Testing
11/19/2009
9
Positive +5.70% BioMedReports: FDA Calendar Updates
07/15/2009
9
Positive +2.22% FDA Calendar Updates: ABII, BMRN, JNJ, OSIP, Roche
07/13/2009
9
Positive +3.24% FDA, Clinical Trial Updates: Heart Stents, Cholesterol in the News
05/20/2009
9
Positive -0.32% FDA Calendar Updates: ACUS, APPY, APPA, ALKS, JNJ
05/18/2009
9
Positive +9.22% FDA, Clinical Trial Updates: Pro-Pharma Looks Promising
04/24/2009
9
Positive +0.10% Highly Defensive Index: Opportunities in Healthcare
04/13/2009
9
Positive -2.12% Updated Clinical Trial and FDA Decision Calendars
03/20/2009
9
Positive +4.49% Updated Clinical Trial and FDA Decision Calendars
03/17/2009
9
Positive +2.31% Cytori Therapeutics: A Natural Play on Cosmetic Medicine
03/01/2009
9
Positive -15.85% FDA Decision Calendar: Pain Drug Delays Likely
02/10/2009
9
Positive +4.41% Three Companies Present at Clear Vision Advisors Event
01/21/2009
9
Positive -5.76% FDA Calendar: Psoriasis Drug Delay is Minor for JNJ
12/20/2008
9
Positive +0.19% FDA Calendar: A Weekly Update
12/05/2008
9
Positive +2.86% A Coiled Spring: Near-Term Catalysts & Oversold Stocks
12/03/2008
9
Positive -0.40% Full Calendar of FDA Decisions
11/30/2008
9
Positive +0.00% Updated 3-Month FDA Calendar
11/30/2008
9
Positive +0.00% Updated 3-Month FDA Calendar
11/29/2008
9
Positive -2.63% A New Global Healthcare Composite Index
11/23/2008
9
Positive +0.00% Updated FDA Calendar of 73 Decision Dates
11/22/2008
9
Positive +7.26% Updated FDA Calendar of 75 Decision Dates
11/21/2008
9
Positive -0.80% Healthcare ETFs Outpace the Market
11/01/2008
9
Positive +0.79% Updated FDA Calendar of 72 Decision Dates
10/30/2008
9
Positive -2.15% Teva is on Target to Acquire Barr
10/29/2008
9
Positive +3.21% My 60 Defensive Growth Stock Picks at Inner8.com
10/25/2008
9
Positive -5.18% FDA Action Heats Up Before Year-End
10/21/2008
9
Positive +0.00% A Defensive Growth Stock Index
10/20/2008
9
Positive -7.06% Pfizer is a Big Pharma Buy
09/24/2008
3
Positive -4.03% Highly Defensive PerformIdex
08/10/2008
4
Positive +5.32% JNJ Is A Core Healthcare Holding
07/19/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch